C

쓰리빌리언

394800KOSDAQ

54.5 / 100

Reference Date: 2026-09-08

Financial Score18.0 / 40
News Sentiment20.5 / 25
Momentum6.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Plunged 19.6% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

3billion is a company leading the diagnosis and development of treatments for rare diseases using AI-based genome interpretation technology, offering genetic testing services such as whole genome and whole exome sequencing. As of 2025, it generates revenue in 75 countries, with 67.4% of sales coming from overseas, and has launched its own genetic variant interpretation software 'GEBRA' as a SaaS product.

Number of Employees

196people

Average Salary

67.2M KRW

Score Calculation Basis

Detailed Financial Score

PER
Industry Average 15.004.0Point
PBR
6.59Industry Average 1.200.0Point

5.5x industry avg (risky)

ROE
-20.87Industry Average 8.000.0Point

Well below industry avg

Debt Ratio
11.50Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2024~20256.0 / 10 points
Revenue Growth Rate
3.0 / 3

Avg ▲102.8% (1-year basis)

Operating Profit Growth Rate
3.0 / 3

Avg ▲20.6% (1-year basis)

ROE Trend
0.0 / 4

Avg ROE -26.8% (improving, 2yr)

Detailed News Sentiment

7 totalPositive 7Neutral 0Negative 0Average Sentiment Score 82.1

Detailed Momentum

52-week position1.0Point

Near 52w low (2%, downtrend)

Current 4,890Won52-week high 18,80052-week low 4,590
1-month return0.0Point

1m -19.57% (strong drop)

Volume trend5.0Point

Volume flat

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0
  • Neutral반기보고서 (2026.06)2026-08-13